Phyton Biotech is the world’s largest producer of Paclitaxel and Docetaxel through its innovative Plant Cell Fermentation (PCF®) technology. The company provides sustainable, scalable solutions for the commercial production of high-value phytochemicals.

Founded with a vision for sustainable biotechnology, Phyton Biotech specialises in the development and manufacturing of plant-derived active pharmaceutical ingredients (APIs). Its proprietary PCF® technology offers cost-effective, environmentally responsible production methods. The company provides services ranging from contract product and process development to full-scale commercial manufacturing, ensuring high-quality, GMP-compliant results.

Key Products and Services

• Paclitaxel (API)
• Docetaxel (API)
• Specialty Fermentation Solutions
• Commercial Downstream Processing
• Active Pharmaceutical Ingredients (APIs)
• Reference Standards

Phyton Biotech continues to lead the industry in delivering sustainable, high-quality biotechnological solutions, addressing the global need for critical, plant-derived pharmaceuticals.